Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.67 % |
3 Month Return | -1.31 % |
1 Year Return | + 109.29 % |
Market Stats | |
Previous Close | ₹1,004.15 |
Open | ₹1,002.05 |
Volume | 45.81K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹2,098.70Cr |
P/E Ratio | 34.27 |
PEG Ratio | 4.73 |
Market Cap | ₹2,098.70 Cr |
P/B Ratio | 2.37 |
EPS | 27.98 |
Dividend Yield | 1.07 |
Sector | Pharmaceuticals |
ROE | 13.63 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹2,098.70 Cr | 29.48% | 0.51 | ₹58 Cr | ₹630 Cr | |
NA | ₹10.17 Cr | 94.34% | 0.88 | NA | NA | |
NA | ₹261.26 Cr | 97.58% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹122.53 Cr | 40.58% | 0.51 | NA | NA | |
NA | ₹14,909.73 Cr | -1.26% | 0.73 | ₹82 Cr | ₹1,465 Cr |
Organisation | Windlas Biotech |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Windlas Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 6 months, WINDLAS stock has moved up by 33.7%
Revenue Rich
Revenue is up for the last 8 quarters, 121.87 Cr → 191.84 Cr (in ₹), with an average increase of 6.2% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 13.48 Cr → 15.66 Cr (in ₹), with an average increase of 13.9% per quarter
Best in 1 Year
In the last 1 year, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Up
Retail Investor have increased holdings from 25.55% to 25.91% in Sep 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 1.59% to 2.00% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 62.51% of holdings in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 8.70% to 7.57% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 62.51% | 0.00 | |
Foreign Institutions | 2% | 25.65 | |
Mutual Funds | 7.57% | ||
Retail Investors | 25.91% | 1.39 | |
Others | 2.01% | 22.00 |
Windlas Biotech in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (34.27x)
January 17, 2025
Industry (54.95x)
January 17, 2025
Highest (38.93x)
December 6, 2024
Windlas Biotech Ltd’s net profit jumped 11.62% since last year same period to ₹15.66Cr in the Q2 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated 16.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.55%.
Read More about DividendsBearish
Neutral
Bullish
Windlas Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Windlas Biotech Ltd share price today stands at ₹1007.3, Open. ₹1002.05 ; Previous Close. ₹1004.15 ; High. ₹1049.55 ; Low. ₹1000 ; 52 Week High. ₹1198.25 ; 52 Week Low: ₹452.55.
Windlas Biotech Ltd is listed on NSE
Windlas Biotech Ltd is listed on BSE
PE Ratio of Windlas Biotech Ltd is 34.27
PE ratio = Windlas Biotech Ltd Market price per share / Windlas Biotech Ltd Earnings per share
Today’s traded volume of Windlas Biotech Ltd(WINDLAS) is 45.81K.
Today’s market capitalisation of Windlas Biotech Ltd(WINDLAS) is ₹2098.7Cr.
Windlas Biotech Ltd(WINDLAS | Price |
---|---|
52 Week High | ₹1198.25 |
52 Week Low | ₹452.55 |
Windlas Biotech Ltd(WINDLAS) share price is ₹1007.3. It is down -15.94% from its 52 Week High price of ₹1198.25
Windlas Biotech Ltd(WINDLAS) share price is ₹1007.3. It is up 122.58% from its 52 Week Low price of ₹452.55
Windlas Biotech Ltd(WINDLAS | Returns |
---|---|
1 Day Returns | 3.15% |
1 Month Returns | -4.67% |
3 Month Returns | -1.31% |
1 Year Returns | 109.29% |